Complete Restriction of Fluoroquinolone Use to Control an Outbreak of Clostridium difficile Infection at a Community Hospital

被引:69
作者
Kallen, Alexander J. [1 ,2 ]
Thompson, Angela [1 ]
Ristaino, Polly [4 ]
Chapman, Leigh [4 ]
Nicholson, Ainsley [1 ]
Sim, Bich-Thuy [1 ]
Lessa, Fernanda [1 ,2 ]
Sharapov, Umid [2 ,3 ]
Fadden, Elaine [4 ]
Boehler, Richard [4 ]
Gould, Carolyn [1 ]
Limbago, Brandi [1 ]
Blythe, David [5 ]
McDonald, L. Clifford [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Preparedness Detect & Control Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Div Foodborne Bacterial & Mycot Dis, Atlanta, GA USA
[4] St Joseph Med Ctr, Towson, MD USA
[5] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA
关键词
NORTH-AMERICA; RISK-FACTOR; DIARRHEA; DISEASE; EPIDEMIC; STRAIN; CLINDAMYCIN; TOXIN; ASSOCIATION; EMERGENCE;
D O I
10.1086/595694
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To review the effect of interventions, including a complete restriction in the use of fluoroquinolones (FQs), used to control an outbreak of hospital-onset Clostridium difficile infection (HO-CDI) caused primarily by the epidemic North American pulsed-field gel electrophoresis type 1 strain. DESIGN. Retrospective cohort and case-control study of all episodes of HO-CDI both before and after 2 interventions. SETTING. Community hospital; January 1, 2005, through March 31, 2007. INTERVENTIONS. Complete, 5-month, facility-wide restriction of fluoroquinolone use, during which a change in the environmental-services contractor occurred. RESULTS. During a 27-month period, 319 episodes of HO-CDI occurred. The hospital-wide mean defined daily doses of antimicrobials decreased 22% after restricting FQ use, primarily because of a 66% decrease in the use of FQs. The interventions were also associated with a significant change in the HO-CDI incidence trends and with an absolute decrease of 22% in HO-CDI cases caused by the epidemic strain (from 66% before the intervention period to 44% during and after the intervention period; P = .02). Univariate analysis revealed that case patients with HO-CDI due to the epidemic strain were more likely than control patients, who did not have diarrhea, to receive a FQ, whereas case patients with HO-CDI due to a nonepidemic strain were not. However, FQ use was not significantly associated with HO-CDI in multivariable analysis. CONCLUSIONS. An outbreak of epidemic-strain HO-CDI was controlled at a community hospital after an overall decrease in antimicrobial use, primarily because of a restriction of FQ use and a change in environmental-services contractors. The restriction of FQ use may be useful as an adjunct control measure in a healthcare facilities during outbreaks of epidemic-strain HO-CDI.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 31 条
[21]   An epidemic, toxin gene-variant strain of Clostridium difficile [J].
McDonald, LC ;
Killgore, GE ;
Thompson, A ;
Owens, RC ;
Kazakova, SV ;
Sambol, SP ;
Johnson, S ;
Gerding, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2433-2441
[22]   Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy [J].
McNulty, C ;
Logan, M ;
Donald, IP ;
Ennis, D ;
Taylor, D ;
Baldwin, RN ;
Bannerjee, M ;
Cartwright, KAV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :707-711
[23]   Control of an outbreak of infection with the hypervirulent clostridium difficile BI strain in a University Hospital using a comprehensive " Bundle" approach [J].
Muto, Carlene A. ;
Blank, Mary Kathleen ;
Marsh, Jane W. ;
Vergis, Emanuel N. ;
O'Leary, Mary M. ;
Shutt, Kathleen A. ;
Pasculle, Anthony W. ;
Pokrywka, Marian ;
Garcia, Juliet G. ;
Posey, Kathy ;
Roberts, Terri L. ;
Potoski, Brian A. ;
Blank, Gary E. ;
Simmons, Richard L. ;
Veldkamp, Peter ;
Harrison, Lee H. ;
Paterson, David L. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (10) :1266-1273
[24]   DECREASE IN NOSOCOMIAL CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA BY RESTRICTING CLINDAMYCIN USE [J].
PEAR, SM ;
WILLIAMSON, TH ;
BETTIN, KM ;
GERDING, DN ;
GALGIANI, JN .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (04) :272-277
[25]   Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec [J].
Pépin, J ;
Saheb, N ;
Coulombe, MA ;
Alary, ME ;
Corriveau, MP ;
Authier, S ;
Leblanc, M ;
Rivard, G ;
Bettez, M ;
Primeau, V ;
Nguyen, M ;
Jacob, CE ;
Lanthier, L .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1254-1260
[26]   A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates [J].
Rupnik, M ;
Avesani, V ;
Janc, M ;
von Eichel-Streiber, C ;
Delmée, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) :2240-2247
[27]  
Siegel J.D., 2007, Guidelines for isolation precaution: preventing transmission of infectious agents in healthcare settings
[28]   Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile [J].
Stubbs, S ;
Rupnik, M ;
Gibert, M ;
Brazier, J ;
Duerden, B ;
Popoff, M .
FEMS MICROBIOLOGY LETTERS, 2000, 186 (02) :307-312
[29]   Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile -: Associated disease caused by the hypervirulent NAP1/027 strain [J].
Valiquette, Louis ;
Cossette, Benoit ;
Garant, Marie-Pierre ;
Diab, Hassan ;
Pepin, Jacques .
CLINICAL INFECTIOUS DISEASES, 2007, 45 :S112-S121
[30]   Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe [J].
Warny, M ;
Pepin, J ;
Fang, A ;
Killgore, G ;
Thompson, A ;
Brazier, J ;
Frost, E ;
McDonald, LC .
LANCET, 2005, 366 (9491) :1079-1084